BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 2445154)

  • 21. Liver biopsies from psoriatics related to methotrexate therapy. 3. Findings in post-methotrexate liver biopsies from 160 psoriatics.
    Nyfors A
    Acta Pathol Microbiol Scand A; 1977 Jul; 85(4):511-8. PubMed ID: 899789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver cirrhosis in rheumatoid arthritis patients treated with long-term methotrexate.
    Minocha A; Dean HA; Pittsley RA
    Vet Hum Toxicol; 1993 Feb; 35(1):45-8. PubMed ID: 8434456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cirrhosis caused by methotrexate in the treatment of psoriasis.
    Muller SA; Farrow GM; Martalock DL
    Arch Dermatol; 1969 Nov; 100(5):523-30. PubMed ID: 5350402
    [No Abstract]   [Full Text] [Related]  

  • 24. Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up.
    Malatjalian DA; Ross JB; Williams CN; Colwell SJ; Eastwood BJ
    Can J Gastroenterol; 1996 Oct; 10(6):369-75. PubMed ID: 9193771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Blood cell concentration of methotrexate in long-term therapy of inflammatory rheumatic diseases].
    Leeb B; Dunky A; Ogris E; Wohanka A; Schenk G; Fischer M; Tausch G; Eberl R
    Acta Med Austriaca; 1988; 15(5):140-4. PubMed ID: 3146207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methotrexate-induced liver cirrhosis. Clinical, histological and serological studies--a further 10-year follow-up.
    Zachariae H; Søgaard H; Heickendorff L
    Dermatology; 1996; 192(4):343-6. PubMed ID: 8864370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate and liver biopsies. Is it really necessary?
    Roenigk HH
    Arch Intern Med; 1990 Apr; 150(4):733-4. PubMed ID: 2327835
    [No Abstract]   [Full Text] [Related]  

  • 28. Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn's disease patients treated with methotrexate.
    Laharie D; Zerbib F; Adhoute X; Boué-Lahorgue X; Foucher J; Castéra L; Rullier A; Bertet J; Couzigou P; Amouretti M; de Lédinghen V
    Aliment Pharmacol Ther; 2006 Jun; 23(11):1621-8. PubMed ID: 16696812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatocellular carcinoma in a patient with psoriasis and methotrexate-induced cirrhosis].
    Mehdi A; Marteau P; Lavergne A; Molho-Sabatier P; Cochand-Priollet B; Caen J; Rambaud JC
    Gastroenterol Clin Biol; 1991; 15(5):464-5. PubMed ID: 1649062
    [No Abstract]   [Full Text] [Related]  

  • 30. Methotrexate-induced liver cirrhosis in a patient of psoriasis.
    Avasthi G; Bhatt P; Singh J
    J Assoc Physicians India; 2012 May; 60():47-8. PubMed ID: 23029724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comment on: Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Boffa MJ; Smith A; Chalmers RJ
    Rheumatology (Oxford); 2009 Nov; 48(11):1464; author reply 1465. PubMed ID: 19671697
    [No Abstract]   [Full Text] [Related]  

  • 32. Natural and Chang liver cell cytotoxic studies of methotrexate-treated psoriatic patients with liver cirrhosis.
    Thestrup-Pedersen K; Laurberg G; Søgaard H; Rønnevig JR
    Acta Derm Venereol; 1988; 68(1):74-7. PubMed ID: 2449016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complications in methotrexate treatment of psoriasis with particular reference to liver fibrosis.
    Ashton RE; Millward-Sadler GH; White JE
    J Invest Dermatol; 1982 Oct; 79(4):229-32. PubMed ID: 7130740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prescription and surveillance of treatment by a systemic agent or biotherapy in psoriasis].
    Boulinguez S
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):8-12. PubMed ID: 20510169
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatic structure and function in psoriasis before and after treatment with methotrexate.
    Barnardo D; Almeyda J; Baker H; Landells J; Levene G
    Gut; 1971 Oct; 12(10):863. PubMed ID: 5123287
    [No Abstract]   [Full Text] [Related]  

  • 36. Tempting liver fibrosis? Long-term psoriatic methotrexate therapy and heterozygous alpha1-antitrypsin deficiency.
    Mathew J; Igbokwe UO; Morley N; Burt AD
    Dermatology; 2006; 213(2):147-9. PubMed ID: 16902293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic fibrosis with the use of methotrexate for juvenile rheumatoid arthritis.
    Keim D; Ragsdale C; Heidelberger K; Sullivan D
    J Rheumatol; 1990 Jun; 17(6):846-8. PubMed ID: 2388211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatotoxicity of long-term methotrexate therapy for psoriasis.
    Tobias H; Auerbach R
    Arch Intern Med; 1973 Sep; 132(3):391-6. PubMed ID: 4783020
    [No Abstract]   [Full Text] [Related]  

  • 39. Have methotrexate-induced liver fibrosis and cirrhosis become rare? A matter for reappraisal of routine liver biopsies.
    Zachariae H
    Dermatology; 2005; 211(4):307-8. PubMed ID: 16286736
    [No Abstract]   [Full Text] [Related]  

  • 40. Liver damage due to methotrexate in patients with psoriasis.
    Dahl MG; Gregory MM; Scheuer PJ
    Br Med J; 1971 Mar; 1(5750):625-30. PubMed ID: 5548839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.